切换至 "中华医学电子期刊资源库"

中华脑科疾病与康复杂志(电子版) ›› 2019, Vol. 09 ›› Issue (05) : 271 -276. doi: 10.3877/cma.j.issn.2095-123X.2019.05.004

所属专题: 文献

临床研究

帕金森病患者认知功能的临床分析
武雅静1, 张丽芳2, 邓远飞2,()   
  1. 1. 518036 深圳,安徽医科大学北京大学深圳医院临床学院
    2. 518036 深圳,北京大学深圳医院特诊病房和老年病科
  • 收稿日期:2019-09-23 出版日期:2019-10-15
  • 通信作者: 邓远飞
  • 基金资助:
    深圳市卫健委三名工程(SZSM201812096)

Clinical analysis of cognitive function in patients with Parkinson’s disease

Yajing Wu1, Lifang Zhang2, Yuanfei Deng2,()   

  1. 1. College of Medicine, Peking University Shenzhen Hospital, Anhui Medical University, Shenzhen 518036, China
    2. Department of Priority Ward and Gerontology, Peking University Shenzhen Hospital, Shenzhen 518036, China
  • Received:2019-09-23 Published:2019-10-15
  • Corresponding author: Yuanfei Deng
  • About author:
    Corresponding author: Deng Yuanfei, Email:
引用本文:

武雅静, 张丽芳, 邓远飞. 帕金森病患者认知功能的临床分析[J]. 中华脑科疾病与康复杂志(电子版), 2019, 09(05): 271-276.

Yajing Wu, Lifang Zhang, Yuanfei Deng. Clinical analysis of cognitive function in patients with Parkinson’s disease[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2019, 09(05): 271-276.

目的

探讨帕金森病(PD)患者认知功能的临床特点及其与病情的关联。

方法

选取2017年2月至2019年9月于北京大学深圳医院神经内科、老年病科门诊及病房就诊的原发性PD患者共96例,以蒙特利尔认知评估(MoCA)量表评定认知,行关期Hoehn-Yahr(H-Y)分期评定。将PD患者分为早期组(H-Y分期2期及以下)和中晚期组(H-Y分期2期以上),比较2组患者的认知功能;使用Logistic回归分析筛选认知功能障碍的保护因素或危险因素,使用相关分析法进行认知得分与H-Y分期的线性相关性研究。

结果

入组PD患者中早期组51例,中晚期组45例,H-Y分期主要集中在1~3期,占全部人群的90.63%。MoCA量表检出认知障碍患病率为67.71%,中晚期PD认知障碍发生率(77.8%)较早期(58.8%)高,差异具有统计学意义(P=0.047),2组患者在年龄、发病年龄、性别、临床首发症状以及受教育年限方面差异均无统计学意义(P>0.05),但中晚期组中位病程(8年)较早期组(4年)长,差异具有统计学意义(P<0.001)。早期组和中晚期组的MoCA量表总得分中位数分别为25分、21分,差异具有统计学意义(P=0.007),且在视空间与执行、命名、警觉性、抽象能力中显示出差别。Logistic回归分析发现受教育年限是认知功能的保护因素(P<0.001,OR=0.703),H-Y分期可能是认知功能的危险因素(P=0.035,OR=1.829)。相关性分析发现认知得分与受教育年限间存在正相关(r=0.610,P<0.001),与H-Y分组间存在负相关(r=-0.320,P=0.002)。

结论

认知障碍在PD中发生率高,认知改变体现在视空间与执行能力、警觉性等方面,未发现年龄、性别、临床首发症状不同带来的认知差异。不可改变的受教育年限是认知功能的保护因素,H-Y分期与未来的认知损害风险有关。

Objective

To explore the clinical characteristics of cognitive function in patients with Parkinson’s disease (PD) and its correlation with the condition.

Methods

A total of 96 patients with idiopathic PD, admitted to Department of Neurology and Geriatrics of Peking University Shenzhen Hospital from February 2017 to September 2019, were included. The Montreal cognitive assessment (MoCA) scale was used to evaluate the cognitive function of PD patients. All patients were assessed with Hoehn-Yahr (H-Y) stage during the off-period. Using the H-Y stage of 2 as a boundary, it was divided into early stage group (H-Y 2 and below) and middle to late stage group (above H-Y 2). The cognitive scores were compared between the two groups. Logistic regression analysis was used to screen for protective factors or risk factors for cognitive dysfunction, and correlation analysis was used to study the linear correlation between cognitive scores and H-Y stages.

Results

There were 51 patients in the early stage group and 45 in the middle to late stage group. The H-Y stage was mainly concentrated in stages 1-3, accounting for 90.63% of the total population. The prevalence of cognitive impairment detected by the MoCA scale was 67.71%, and the incidence of PD cognitive impairment in middle to late stage group was higher than the early stage group (77.8% vs 58.8%, P=0.047). There was no difference in age, age of onset, gender, clinical onset symptoms, and years of education between the two groups; while the course of disease showed different, the median course of disease in the middle to late stage group was longer than that of the early stage group (8 years vs 4 years, P<0.001). The total score of the MoCA scale was different (P=0.007), the median total score was 25 points and 21 points, showing differences in visuospatial and executive function, naming, alertness, and abstraction. Logistic regression analysis found that years of education was a protective factor of cognitive function (P<0.001, OR=0.703), and H-Y stage would be a risk factor (P=0.035, OR=1.829). Correlation analysis found that there was a positive correlation between cognitive score and years of education (r=0.610, P<0.001), and a negative correlation between cognitive score and the adjusted H-Y stages(r=-0.320, P=0.002).

Conclusion

Cognitive dysfunction has a high incidence in PD, mainly showed in visuospatial and executive function, alertness. No cognitive differences caused by age, gender, and clinical onset symptoms were found. Years of education cannot be changed, and it is a protective factor for cognitive function. H-Y stage is related to the risk of cognitive impairment in the future.

表1 早期和中晚期帕金森病患者的临床特点及认知功能比较
表2 MoCA量表得分比较[M(IQR)]
表3 MoCA量表认知功能Logistic回归分析
图1 MoCA量表得分与受教育年限、H-Y分组的相关性分析
[1]
Monastero R, Cicero CE, Baschi R, et al. Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)[J]. J Neurol, 2018, 265(5): 1050-1058.
[2]
Aarsland D, Andersen K, Larsen JP, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year Prospective study[J]. Arch Neurol, 2003, 60(3): 387-392.
[3]
Reid WG, Hely MA, Morris JG, et al. A longitudinal of Parkinson’s disease: clinical and neuropsychological correlates of dementia[J]. J Clin Neurosci, 1996, 3(4): 327-333.
[4]
Fernandez HH, Lapane KL. Predictors of mortality among nursing home residents with a diagnosis of Parkinson’s disease[J]. Med Sci Monit, 2002, 8(4): Cr241-Cr246.
[5]
Bäckström D, Granösen G, Domellöf ME, et al. Early predictors of mortality in Parkinsonism and Parkinson disease: a population-based study[J]. Neurology, 2018, 91(22): e2045-e2056.
[6]
Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease[J]. Mov Disord, 2015, 30(12): 1591-1601.
[7]
Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines[J]. Mov Disord, 2012, 27(3): 349-356.
[8]
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician[J]. J Psychiatr Res, 1975, 12(3): 189-198.
[9]
Hoops S, Nazem S, Siderowf AD, et al. Validity of the moca and mmse in the detection of mci and dementia in Parkinson disease[J]. Neurology, 2009, 73(21): 1738-1745.
[10]
Dalrymple-Alford JC, MacAskill MR, Nakas CT, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease[J]. Neurology, 2010, 75(19): 1717-1725.
[11]
Brown DS, Bernstein IH, McClintock SM, et al. Use of the montreal cognitive assessment and Alzheimer’s disease-8 as cognitive screening measures in Parkinson’s disease[J]. Int J Geriatr Psychiatry, 2016, 31(3): 264-272.
[12]
Ozer S, Young J, Champ C, et al. A systematic review of the diagnostic test accuracy of brief cognitive tests to detect amnestic mild cognitive impairment[J]. Int J Geriatr Psychiatry, 2016, 31(11): 1139-1150.
[13]
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality[J]. Neurology, 1967, 17(5): 427-442.
[14]
Wu L, Liu FT, Ge JJ, et al. Clinical characteristics of cognitive impairment in patients with Parkinson’s disease and its related pattern in 18F-FDG pet imaging[J]. Hum Brain Mapp, 2018, 39(12): 4652-4662.
[15]
Nie K, Gao Y, Mei M, et al. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson’s disease and the analysis of relevant factors[J]. J Clin Neurosci, 2019, 63: 142-148.
[16]
Cholerton B, Johnson CO, Fish B, et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson’s disease[J]. Parkinsonism Relat Disord, 2018, 50: 29-36.
[17]
Buter TC, van den Hout A, Matthews FE, et al. Dementia and survival in Parkinson disease: a 12-year population study[J]. Neurology, 2008, 70(13): 1017-1022.
[18]
Galtier I, Nieto A, Lorenzo JN, et al. Mild cognitive impairment in Parkinson’s disease: diagnosis and progression to dementia[J]. J Clin Exp Neuropsychol, 2016, 38(1): 40-50.
[19]
Lichter DG, Benedict RHB, Hershey LA. Importance of balance-gait disorder as a risk factor for cognitive impairment, dementia and related non-motor symptoms in Parkinson’s disease[J]. J Parkinsons Dis, 2018, 8(4): 539-552.
[20]
Muslimovic D, Post B, Speelman JD, et al. Determinants of disability and quality of life in mild to moderate Parkinson disease[J]. Neurology, 2008, 70(23): 2241-2247.
[21]
Mirza SS, Ikram MA, Bos D, et al. Mild cognitive impairment and risk of depression and anxiety: a population-based study[J]. Alzheimers Dement, 2017, 13(2): 130-139.
[22]
Schrag A, Siddiqui UF, Anastasiou Z, et al. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson’s disease: a cohort study[J]. Lancet Neurol, 2017, 16(1): 66-75.
[1] 王诗远, 张爱华. 慢性肾脏病相关认知障碍的发生机制研究进展[J]. 中华肾病研究电子杂志, 2023, 12(03): 163-167.
[2] 金刚, 李英真, 施维, 李博. 帕金森病在病理生理学中的研究进展[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 315-319.
[3] 李玺琳, 章邱东. 帕金森病患者胃肠功能障碍特点及其风险因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 145-149.
[4] 常文轩, 王婷, 刘伟, 蓝天琦, 彭静, 汪诗瑶, 张晓鹏, 冯晨, 宫雪梅, 朱敏. 脑小血管病所致执行障碍的研究进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 179-182.
[5] 赵金义, 孙正莹, 李洪义, 胡明成, 王晓申, 史晓航, 王煜宁, 孙维洋, 邢健. 基于结构磁共振成像评估皮质下缺血性脑血管病伴认知障碍患者灰质萎缩的影像学研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(01): 10-14.
[6] 耿磊, 张照婷, 许磊, 黄海, 孙毅, 杨伏猛, 徐凯, 胡春峰. 帕金森病前驱期基底神经节环路磁共振弥散张量成像的应用研究[J]. 中华临床医师杂志(电子版), 2023, 17(9): 995-1003.
[7] 杨团峰, 孟雪, 王艳香, 卢葭, 孔德生, 赵元立, 刘献增. 男性帕金森病患者球海绵体肌反射初步研究[J]. 中华临床医师杂志(电子版), 2023, 17(01): 28-32.
[8] 谢艾伦, 郑冬燕, 蔡紫薇, 卢仁建, 彭永明, 张贺, 陈家隆. 鱼藤酮通过降低线粒体钙离子单向转运体蛋白表达促进多巴胺能神经元铁死亡[J]. 中华临床实验室管理电子杂志, 2023, 11(02): 71-78.
[9] 郭如烨, 孟黎明, 陈楠, 宋玉莹, 尹海燕, 郭岩. Apelin/APJ系统对帕金森病模型的神经保护作用及机制研究进展[J]. 中华诊断学电子杂志, 2023, 11(04): 276-282.
[10] 韩远远, 于紫涵, 杨玲, 程弘禹, 宋春杰. C反应蛋白与白蛋白比值和中性粒细胞与淋巴细胞比值对老年帕金森病的诊断价值[J]. 中华老年病研究电子杂志, 2023, 10(01): 14-19.
[11] 孙畅, 赵世刚, 白文婷. 脑卒中后认知障碍与内分泌激素变化的关系[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 471-476.
[12] 王道合, 施媛媛. 8-iso-PGF2α及P选择素在评估脑小血管病患者认知功能中的价值[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 364-368.
[13] 夏禹, 刘寒, 朱瑞. 阿尔茨海默病及相关认知障碍疾病与早老素2基因相关性的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 290-293.
[14] 张宇, 蔡玉洁, 林日清, 邱钦杰, 崔理立, 郑东, 周海红. 张力蛋白1对放射性脑损伤小鼠认知功能的影响[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 244-253.
[15] 楚长彪. 卒中后认知障碍的管理[J]. 中华脑血管病杂志(电子版), 2023, 17(02): 0-.
阅读次数
全文


摘要